Real-world persistence with liraglutide 3.0 mg for weight management and the SaxendaCare® patient support program.

These findings suggest that, in clinical settings, persistence with liraglutide 3.0 mg can exceed 6 months, and that enrolling in SaxendaCare® may be associated with comparatively longer persistence and, regardless of persistence, greater weight loss.